Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer:
Focus on Immunotherapy and Nanotechnology
:
Ferroptosis is a newly discovered form of programmed cell death characterized by
iron overload, ROS accumulation, and lipid peroxidation. It is distinguished by unique morphological, biochemical, and genetic features and stands apart from other known regulated cell
death mechanisms. Studies have demonstrated a close association between ferroptosis and various cancers, including liver cancer, lung cancer, renal cell carcinoma, colorectal cancer, pancreatic cancer, and ovarian cancer. Inducing ferroptosis has shown promising results in inhibiting
tumor growth and reversing tumor progression. However, the challenge lies in regulating ferroptosis in vivo due to the scarcity of potent compounds that can activate it. Integrating emerging
biomedical discoveries and technological innovations with conventional therapies is imperative.
Notably, considerable progress has been made in cancer treatment by leveraging immunotherapy
and nanotechnology to trigger ferroptosis. This review explores the relationship between ferroptosis and emerging immunotherapies and nanotechnologies, along with their potential underlying mechanisms, offering valuable insights for developing novel cancer treatment strategies.
